USPTO serial 79380030
NORDICPRO-C3
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 9, 2025
- Examiner
- BIBB, SCOTT
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NORDICPRO-C3?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew M. Smith
Andrew M. Smith Resonate IP, LLCP.O. Box 165012 Fulwood PlaceBend, OR 97709Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; diagnostic biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detection, disease detection, disease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical use | ACTIVE | — |
| 042 | custom design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; custom design and development of biochemical, pharmaceutical, and medical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysis, namely, analysis of pharmacodynamic data; biological research and analysis, namely, analysis of data relating to biomarkers; development services in the field of diagnostic preparations, equipment and tests; medical and scientific research, namely, conducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; advice, information and assistance relating to the foregoing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nordic Bioscience A/S
- Other trademarks owned by Nordic Bioscience A/S
- Other trademarks owned by Nordic Bioscience A/S
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named NORDICPRO-C3
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 22, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 9, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 24, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 24, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 9, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 9, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 9, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 22, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 22, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 16, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 17, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 17, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 17, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 17, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 17, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 22, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 4, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 4, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 27, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 8, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 8, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 3, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 2, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 10, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 6, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 5, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |